Search

Your search keyword '"Klenerman, P."' showing total 2,132 results

Search Constraints

Start Over You searched for: Author "Klenerman, P." Remove constraint Author: "Klenerman, P."
2,132 results on '"Klenerman, P."'

Search Results

51. HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV

52. CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study

53. Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents

54. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

55. Spectrally-Resolved Photodynamics of Individual Emitters in Large-Area Monolayers of Hexagonal-Boron Nitride

56. Antigen discrimination by T cells relies on size-constrained microvillar contact

57. Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response

58. Direct digital sensing of protein biomarkers in solution

59. The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity

60. Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

62. Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial

63. Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

64. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

65. A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and mice

66. P1095: COVID-19 VACCINE RESPONSES IN FOLLICULAR LYMPHOMA: DETERMINANTS OF HUMORAL AND CELLULAR IMMUNITY IN THE PETREA TRIAL OF FRONTLINE CHEMOIMMUNOTHERAPY

67. Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members

68. T cell immune memory after covid-19 and vaccination

69. Super-resolution imaging unveils the self-replication of tau aggregates upon seeding

72. Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity

73. Structure-specific amyloid precipitation in biofluids

75. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

76. SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

78. Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease

79. Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch databaseResearch in context

80. Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses

81. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

82. Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism

84. Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses

85. BreakAlign: a Perl program to align chimaeric (split) genomic NGS reads and allow visual confirmation of novel retroviral integrations

86. The 2015 super-resolution microscopy roadmap

87. An Interpretable Classification Model Using Gluten-Specific TCR Sequences Shows Diagnostic Potential in Coeliac Disease

88. An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

89. Divergent trajectories of antiviral memory after SARS-CoV-2 infection

90. Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound

91. Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort studyResearch in context

92. Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury

93. Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion

94. Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors

97. Divergent trajectories of antiviral memory after SARS-CoV-2 infection

99. A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and mice

Catalog

Books, media, physical & digital resources